Literature DB >> 8034718

A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes.

S Masuda1, M Okano, K Yamagishi, M Nagao, M Ueda, R Sasaki.   

Abstract

It has been shown that neurons express erythropoietin (Epo) receptor, but the production of Epo protein in neural tissues has not been demonstrated. Cerebral cells of rat fetuses were cultured, and Epo in the spent medium was measured with an enzyme-linked immunoassay. Production of the immunoreactive Epo was dependent on O2 tension for cell culture; hypoxia enhanced the production. The immunoreactive Epo purified from the spent medium stimulated the growth of Epo-dependent myeloid cells and formation of fetal liver erythroid colonies. These biological activities were completely inhibited by the anti-Epo antiserum and the extracellular domain of the Epo receptor capable of binding with Epo. When brain Epo was compared with serum Epo, brain Epo was smaller in size and more active in vitro at low ligand concentrations. These differences appear to be caused by the different extent of sialylation. Analyses with the reverse transcription-polymerase chain reaction method indicated that the regulation of Epo production by oxygen operates at the level of its mRNA. Immunochemical staining of the immortalized clonal cells revealed that astrocytes produced brain Epo. These results provide a novel site of Epo production and suggest that Epo acts on neurons in a paracrine fashion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034718

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

1.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

2.  Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling.

Authors:  Erica A Dale; Irawan Satriotomo; Gordon S Mitchell
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

Review 3.  Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function.

Authors:  E A Dale; F Ben Mabrouk; G S Mitchell
Journal:  Physiology (Bethesda)       Date:  2014-01

4.  Breath holding spells in 91 children and response to treatment with iron.

Authors:  H Mocan; A Yildiran; F Orhan; E Erduran
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 5.  The neurobiology of erythropoietin.

Authors:  Arthur J Sytkowski
Journal:  Cell Mol Neurobiol       Date:  2011-05-03       Impact factor: 5.046

6.  Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.

Authors:  Bing Zhou; Jeffrey S Damrauer; Sean T Bailey; Tanja Hadzic; Youngtae Jeong; Kelly Clark; Cheng Fan; Laura Murphy; Cleo Y Lee; Melissa A Troester; C Ryan Miller; Jian Jin; David Darr; Charles M Perou; Ross L Levine; Maximilian Diehn; William Y Kim
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

7.  Erythropoietin negatively regulates pituitary ACTH secretion.

Authors:  Soumyadeep Dey; Tyler Scullen; Constance Tom Noguchi
Journal:  Brain Res       Date:  2015-03-09       Impact factor: 3.252

Review 8.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  Promotion of neurite outgrowth and protective effect of erythropoietin on the retinal neurons of rats.

Authors:  Yisheng Zhong; Huiping Yao; Lianfu Deng; Yu Cheng; Xiaoqing Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-09       Impact factor: 3.117

10.  Erythropoietin improves operant conditioning and stability of cognitive performance in mice.

Authors:  Ahmed El-Kordi; Konstantin Radyushkin; Hannelore Ehrenreich
Journal:  BMC Biol       Date:  2009-07-08       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.